These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35093157)

  • 1. Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression.
    Kang E; Kim YM; Choi Y; Lee Y; Kim J; Choi IH; Yoo HW; Yoon HM; Lee BH
    Orphanet J Rare Dis; 2022 Jan; 17(1):24. PubMed ID: 35093157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Value of Multiparametric Whole-Body Magnetic Resonance Imaging over Whole-Spine Magnetic Resonance Imaging in Patients with Neurofibromatosis Type I.
    Zhang L; Dessouky R; Xi Y; Chhabra A; Le LQ
    World Neurosurg; 2017 Dec; 108():729-737. PubMed ID: 28939538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics.
    Liu Y; Jordan JT; Bredella MA; Erdin S; Walker JA; Vangel M; Harris GJ; Plotkin SR; Cai W
    Neurology; 2020 Jun; 94(24):e2521-e2531. PubMed ID: 32345730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment.
    Attia S; Guirguis M; Le LQ; Chhabra A
    Skeletal Radiol; 2024 Apr; 53(4):769-777. PubMed ID: 37903998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI.
    Ly KI; Merker VL; Cai W; Bredella MA; Muzikansky A; Thalheimer RD; Da JL; Orr CC; Herr HP; Morris ME; Chang CY; Harris GJ; Plotkin SR; Jordan JT
    Neurology; 2023 Feb; 100(7):e661-e670. PubMed ID: 36332985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
    Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
    PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.
    Mautner VF; Asuagbor FA; Dombi E; Fünsterer C; Kluwe L; Wenzel R; Widemann BC; Friedman JM
    Neuro Oncol; 2008 Aug; 10(4):593-8. PubMed ID: 18559970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
    Salamon J; Mautner VF; Adam G; Derlin T
    Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor segmentation of whole-body magnetic resonance imaging in neurofibromatosis type 1 patients: tumor burden correlates.
    Heffler MA; Le LQ; Xi Y; Chhabra A
    Skeletal Radiol; 2017 Jan; 46(1):93-99. PubMed ID: 27815599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion.
    Urban T; Lim R; Merker VL; Muzikansky A; Harris GJ; Kassarjian A; Bredella MA; Plotkin SR
    Clin Nucl Med; 2014 May; 39(5):e301-7. PubMed ID: 24152623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C2 neurofibromas in neurofibromatosis type 1: genetic and imaging characteristics.
    Waqar M; Huson S; Evans DG; Ealing J; Karabatsou K; George KJ; Soh C
    J Neurosurg Spine; 2019 Jan; 30(1):126-132. PubMed ID: 30485203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.
    Plotkin SR; Bredella MA; Cai W; Kassarjian A; Harris GJ; Esparza S; Merker VL; Munn LL; Muzikansky A; Askenazi M; Nguyen R; Wenzel R; Mautner VF
    PLoS One; 2012; 7(4):e35711. PubMed ID: 22558206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric whole-body MRI of patients with neurofibromatosis type I: spectrum of imaging findings.
    Thakur U; Ramachandran S; Mazal AT; Cheng J; Le L; Chhabra A
    Skeletal Radiol; 2024 Aug; ():. PubMed ID: 39105762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
    Well L; Döbel K; Kluwe L; Bannas P; Farschtschi S; Adam G; Mautner VF; Salamon J
    PLoS Genet; 2021 May; 17(5):e1009517. PubMed ID: 33951044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.
    Tucker T; Friedman JM; Friedrich RE; Wenzel R; Fünsterer C; Mautner VF
    J Med Genet; 2009 Feb; 46(2):81-5. PubMed ID: 18930997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 1 and the pediatric neurosurgeon: a 20-year institutional review.
    Farmer JP; Khan S; Khan A; Ortenberg J; Freeman C; O'Gorman AM; Montes J
    Pediatr Neurosurg; 2002 Sep; 37(3):122-36. PubMed ID: 12187057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characterization of children and adolescents with NF1 microdeletions.
    Kehrer-Sawatzki H; Kluwe L; Salamon J; Well L; Farschtschi S; Rosenbaum T; Mautner VF
    Childs Nerv Syst; 2020 Oct; 36(10):2297-2310. PubMed ID: 32533297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phenotypic and genetic features in neurofibromatosis type 1 in children].
    Duat Rodríguez A; Martos Moreno GÁ; Martín Santo-Domingo Y; Hernández Martín A; Espejo-Saavedra Roca JM; Ruiz-Falcó Rojas ML; Argente J
    An Pediatr (Barc); 2015 Sep; 83(3):173-82. PubMed ID: 25541118
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.